Celltrion Pharm, Inc. (KOSDAQ:068760)
South Korea · Delayed Price · Currency is KRW 53,800
-300 (-0.55%)
Oct 10, 2025, 3:30 PM KST
Celltrion Pharm Market Cap
Celltrion Pharm has a market cap or net worth of 2.34 trillion as of October 10, 2025. Its market cap has decreased by -15.81% in one year.
Market Cap
2.34T
Enterprise Value
n/a
Revenue
274.73B
Ranking
n/a
PE Ratio
90.42
Stock Price
53,800.00
Market Cap Chart
Since February 3, 2006, Celltrion Pharm's market cap has increased from 66.37B to 2.34T, an increase of 3,425.66%. That is a compound annual growth rate of 19.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 2,353.08B | -4.60% |
| Dec 30, 2024 | 2,466.43B | -35.41% |
| Dec 28, 2023 | 3,818.49B | 44.48% |
| Dec 29, 2022 | 2,642.93B | -43.45% |
| Dec 30, 2021 | 4,673.68B | -46.31% |
| Dec 30, 2020 | 8,705.45B | 511.51% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |